# OnCo record ga68-psma-11 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ga68-psma-11/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ga68-psma-11" ;
  schema:name "Gallium-68 gozetotide (PSMA-11)"@en ;
  schema:description "Gallium-68 PSMA-11 was the first PSMA PET tracer approved in the US (2020), and is made on site from a generator or cyclotron."@en ;
  schema:url <https://onco.cc/drugs/ga68-psma-11/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Gallium-68%20gozetotide> ;
  onco:status "approved" ;
  onco:modality "PET imaging agent" ;
  schema:alternateName "Illuccix / Gozellix / Locametz" ;
  onco:approval "US 2020: PSMA PET (UCLA/UCSF NDA); kits 2021-2022" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/psma-pet/> ;
  onco:targets <https://onco.cc/targets/psma/> ;
  onco:companies <https://onco.cc/companies/telix/>, <https://onco.cc/companies/novartis/> ;
  onco:institutions <https://onco.cc/institutions/ucla-jonsson/>, <https://onco.cc/institutions/ucsf/> ;
  onco:trials <https://onco.cc/trials/psma-prerp/>, <https://onco.cc/trials/nct07052214/> .